eConsent Solutions

eConsent Feedback Form

  • TransCelerate BioPharma Inc. may contact you by email to provide input on future eConsent materials.

The TransCelerate eConsent Initiative aims to create general awareness and enable broad, voluntary implementation of eConsent. The eConsent Initiative has developed practical guidance and tools describing potential implementation considerations and eConsent components. As of December 2021, this initiative is complete. No new solutions or updates are planned.

Use of eConsent may help improve patients’ understanding of study objectives and design, increase regulatory compliance, and reduce quality risks. Data from eConsent pilots suggest that patients prefer multimedia content and on-demand access to consent tools via the web or mobile device over the traditional paper process. Successful adoption of eConsent may empower patients and the families that care for them to proceed through a clinical study better informed.

The eConsent Initiative has collaborated with patients and sites, health authorities (HAs) and institutional review boards (IRBs)/independent ethics committees (IECs), and clinical research organizations (CROs) to develop The eConsent Implementation Guidance and tools.

Below interactively explore components of our eConsent Implementation Guidance, supporting tools and resources.

Click on each section to navigate through the content.
What is eConsent?
Multimedia Components
Implementation Guidance
Supporting Tools & Resources

More About eConsent

Thank you!

TransCelerate's solutions are designed through a collaborative process in which thought leaders from member companies participate. Integral to the development of these perspectives is our engagement and robust partnerships with organizations across the ecosystem.

Thank you to the patients, sites, ethics committees and institutional review boards, clinical research organizations, health authorities, and technology providers that have helped us create these valuable insights on eConsent for the industry.